Ajenat Pharmaceuticals, LLC
GlatiramerAcetateInjections.com
Effective Date: May 27, 2026
Last Updated: May 27, 2026
Welcome to GlatiramerAcetateInjections.com (the “Site”), operated by Ajenat Pharmaceuticals, LLC (“Ajenat,” “we,” “us,” or “our”). By accessing or using this Site, you agree to be bound by these Terms of Use (“Terms”). If you do not agree to these Terms, please do not access or use the Site.
These Terms apply to all visitors, patients, caregivers, healthcare professionals, and any other users of the Site. We reserve the right to modify these Terms at any time. Changes become effective upon posting to the Site with an updated “Last Updated” date. Your continued use of the Site after any changes constitutes your acceptance of the revised Terms.
This Site is intended for residents of the United States who are 18 years of age or older, including patients, caregivers, and licensed healthcare professionals (HCPs) seeking information about Glatiramer Acetate Injection. The product information, prescribing information, and resources available on this Site are specific to the United States market and are governed by U.S. Food and Drug Administration (FDA) regulations.
This Site is not intended for use by individuals outside the United States. Residents of other countries should consult local healthcare providers and regulatory authorities for information about glatiramer acetate products approved in their jurisdiction.
This Site is not directed to individuals under 18 years of age. If you are under 18, please do not use this Site.
The content on this Site is provided for informational and educational purposes only. Nothing on this Site constitutes medical advice, diagnosis, treatment recommendations, or a substitute for the judgment of a qualified healthcare professional. All medical decisions – including decisions regarding the use, continuation, or discontinuation of Glatiramer Acetate Injection – should be made in consultation with your physician, neurologist, or other licensed healthcare provider.
All product-related content on this Site is based on FDA-approved labeling, including the Full Prescribing Information, Medication Guide, and Instructions for Use. Ajenat does not promote Glatiramer Acetate Injection for any use not described in the approved labeling. Nothing on this Site should be interpreted as encouraging off-label use of any medication.
Information provided on this Site that is directed to healthcare professionals is intended to support clinical decision-making and does not replace independent clinical judgment. Healthcare professionals should refer to the complete Full Prescribing Information, including the Boxed Warning and all contraindications, warnings, and precautions, before prescribing or recommending Glatiramer Acetate Injection.
This Site is not designed or intended to handle medical emergencies. If you or someone you know is experiencing a medical emergency, including a serious allergic reaction (anaphylaxis) following an injection, call 911 or go to the nearest emergency room immediately. For adverse event reporting, contact FDA MedWatch at 1-800-FDA-1088 or visit fda.gov/medwatch.
All content on this Site – including but not limited to text, graphics, logos, images, page layouts, design elements, icons, and downloadable materials – is the property of Ajenat Pharmaceuticals, LLC or its content licensors and is protected by United States and international copyright, trademark, and intellectual property laws. The Ajenat name, logo, and all related marks are trademarks of Ajenat Pharmaceuticals, LLC.
You may access and view the content on this Site for your own personal, non-commercial informational use. You may print or download a single copy of materials from this Site for personal reference, provided you do not modify the content and retain all copyright and proprietary notices.
Except as expressly permitted in Section 4.2, you may not, without prior written permission from Ajenat:
Requests for permission to reproduce or republish Site content may be directed to info@ajenatpharma.com.
The Full Prescribing Information (PI), Medication Guide, and Instructions for Use (IFU) for Glatiramer Acetate Injection 20 mg/mL and 40 mg/mL are made available on this Site as required by FDA regulations. These documents are provided as official FDA-approved labeling and are not authored by this Site. Links to the official DailyMed database (maintained by the U.S. National Library of Medicine) are provided for reference.
Prescribing information is subject to revision. Always refer to the most current version of the Full Prescribing Information when making clinical or treatment decisions.
This Site contains links to third-party websites and resources, including but not limited to DailyMed, FDA MedWatch, and MS patient support organizations. These links are provided for informational convenience only. Ajenat does not control, endorse, or assume responsibility for the content, accuracy, privacy practices, or availability of any third-party website.
Your use of any third-party website is governed by that site’s own terms of use and privacy policy. We encourage you to review those policies before providing any personal information to a third-party site.
This Site includes or will include injection training resources such as step-by-step instructions, injection site diagrams, and instructional video content. This content is intended to supplement – not replace – the training provided by your healthcare provider or pharmacist. Always follow the Instructions for Use included with your medication and consult your healthcare provider with any questions about proper injection technique.
Video content, when available, may be hosted on or through a third-party video platform. Ajenat is not responsible for the terms of use, privacy practices, or availability of any third-party video hosting service.
When you submit information through the Contact Us form on this Site, you agree that the information you provide is accurate and that you are authorized to submit it. You agree not to submit false, misleading, defamatory, or unlawful content through any form or feature on this Site.
Any information you submit through the Contact Us form will be handled in accordance with our Privacy Policy. Submitting a message through the contact form does not create a physician-patient relationship, a pharmacist-patient relationship, or any other professional relationship between you and Ajenat.
This Site is not intended for the submission of adverse event reports, product complaints, or medical information requests. To report an adverse event or product quality complaint, please contact FDA MedWatch at 1-800-FDA-1088 or visit fda.gov/medwatch.
THIS SITE AND ALL CONTENT ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, AJENAT DISCLAIMS ALL WARRANTIES, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.
Ajenat does not warrant that: (a) the Site will be uninterrupted, error-free, or free of viruses or other harmful components; (b) the content on the Site is complete, accurate, or current; or (c) any defects in the Site will be corrected. You assume full responsibility for your use of the Site and any reliance on its content.
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, AJENAT PHARMACEUTICALS, LLC, ITS OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, LICENSORS, AND SERVICE PROVIDERS SHALL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES ARISING OUT OF OR RELATED TO YOUR USE OF, OR INABILITY TO USE, THIS SITE OR ITS CONTENT, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
In no event shall Ajenat’s total liability to you for all claims arising from your use of this Site exceed one hundred dollars ($100.00). Some jurisdictions do not allow the exclusion or limitation of certain damages; in such jurisdictions, our liability is limited to the greatest extent permitted by law.
You agree to indemnify, defend, and hold harmless Ajenat Pharmaceuticals, LLC and its officers, directors, employees, agents, and licensors from and against any claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys’ fees) arising out of or related to: (a) your use of the Site in violation of these Terms; (b) your violation of any applicable law or regulation; or (c) any content you submit through the Site.
These Terms are governed by and construed in accordance with the laws of the State of Florida and applicable federal law, without regard to conflict of law principles. Any legal action or proceeding arising under or related to these Terms shall be brought exclusively in the state or federal courts located in Pinellas County, Florida, and you consent to the personal jurisdiction of such courts.
If any provision of these Terms is found to be invalid, unlawful, or unenforceable under applicable law, that provision shall be modified to the minimum extent necessary to make it enforceable, or severed if modification is not possible, without affecting the validity or enforceability of the remaining provisions.
These Terms, together with our Privacy Policy, constitute the entire agreement between you and Ajenat Pharmaceuticals, LLC with respect to your use of this Site and supersede all prior or contemporaneous agreements, representations, or understandings relating to the same subject matter.
If you have questions or concerns regarding these Terms of Use, please contact us:
Ajenat Pharmaceuticals, LLC
6911 Bryan Dairy Road
Largo, FL 33777
Email: info@ajenatpharma.com
© 2026 Ajenat Pharmaceuticals, LLC. All rights reserved. Glatiramer Acetate Injection is an FDA-approved prescription medicine. This website is intended for U.S. residents only.